This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
We are deeply honored to be recognized in Everest Group’s PEAK Matrix® for LifeSciences CTMS solutions,” said Dinesh Kashyap, CEO and Founder of Cloudbyz. Our mission is to enable faster, more efficient trials, ultimately supporting the delivery of life-saving therapies.”
It is no secret that Canada boasts a strong and competitive lifesciences sector. Within Canada, one province has often stood out as the place to be for cutting-edge lifesciences innovation. Canada’s next lifesciences leader. Again, this is nothing new. Now, there is no slowing down.
The lifesciences history industry has some unique challenges when it comes to compliance. Early lifescience pioneers in foreign markets earned a reputation for lax ethical behaviour, making them a prime target for regulators. In 2020, lifescience firms accounted for a third of the SEC’s enforcement actions.
The growth in sales was driven by all regions and business sectors, particularly LifeScience. to €10.38bn in its LifeScience business during the year. The EBITDA pre of LifeScience grew by 14.4% Merck has reported an increase in group net sales by 12.9% to €22.23bn in fiscal 2022 against €19.68bn in 2021.
Jordyn has a Master’s degree in social work and licenses/certifications in cognitive behavioral therapy. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. Jordyn is also a Clinical Consultant and Trainer at Waypoint Centre for Mental Health Care, as well as an advocate for cancer prevention.
Although some lifesciences companies are starting to shift to incorporate human-centered design practices, it is often coming late in the drug development process – well into the commercialisation efforts of launch planning, if not post-launch. gain insights to inform trial design and optimal target product profiles.
ERS Genomics and G+FLAS LifeSciences sign CRISPR/Cas9 license agreement ERS Genomics and G+FLAS LifeSciences sign CRISPR/Cas9 license agreement G+FLAS LifeSciences is applying CRISPR technology to develop research tools and reagents DUBLIN & SEOUL–(BUSINESS WIRE)–ERS Genomics Limited, which … Continue reading →
Receptor LifeSciences Receives Schedule I Research License from U.S. Drug Enforcement Agency Receptor LifeSciences Receives Schedule I Research License from U.S. 16, 2020 (GLOBE NEWSWIRE) — Receptor LifeSciences announced today that the … Continue reading →
The arrival of G7 health ministers to Oxford this week (Thursday 3 June) will shine a spotlight on Oxfordshire’s considerable achievements in the lifesciences sector – and, according to the county’s Local Enterprise Partnership, there couldn’t be a better location globally for this summit to be held.
Current Share Price: The announcement follows a $115 million Series D financing in December 2024, co-led by Frazier LifeSciences and Deep Track Capital, with participation from Janus Henderson Investors and Logos Capital. To further expand its research, Maze has entered several strategic partnerships and licensing agreements.
The lifesciences and healthcare are among the biggest industries globally, and their significance was particularly highlighted during the past couple of years by the COVID-19 pandemic. Given the hyperfocus on the lifesciences thanks to COVID, consumers appear to be more autonomous and vocal about their medical demands and choices.
Nearly five years to the day after striking the deal, AVEO Oncology and CANbridge LifeSciences announce the termination of their collaboration and licensing agreement for AVEO’s AV-203.
Dr. Marcondes is a licensed and trained physician, specializing in oncology and immune oncology. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode. He has more than 15 years of research and teaching experience in Bone Marrow Transplant (BMT)/Cellular Therapies and more than 10 years of industry experience.
Precision BioSciences and Tiziana LifeSciences Announce Exclusive License Agreement to Evaluate Foralumab, a Novel, Fully Human Anti-CD3 Monoclonal Antibody, in Conjunction with Allogeneic CAR T Candidates for Cancer Treatment Precision BioSciences and Tiziana LifeSciences Announce Exclusive License Agreement … Continue reading →
Before the Covid-19 pandemic, government-led investment and engagement in lifesciences was relatively restricted worldwide, with the industry mostly funded via private investment. As a result, multiple vaccines, including Pfizer /BioNTech’s mRNA vaccine, Comirnaty, were licensed for use within a year of development beginning.
16th Annual LifeSciences Trade and Channel Strategies. December 1-3, 2020 | Virtual Event www.informaconnect.com/trade-channel. Get ready to hit the ground running in 2021 by closing out the year at Trade and Channel 2020 !
In this episode, Ayesha discussed a new COVID-19 test technology that Innova Medical Group, world leader in at-home COVID-19 tests, has reached a licensing deal for with the University of Birmingham where the technology was developed. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
These efforts aim to fast-track commercialization and out-licensing agreements in one of the world’s most promising pharmaceutical markets. International patents valid until 2036 further strengthen its global positioning.
In this episode, Ayesha talked about the FDA’s acceptance of AstraZeneca’s supplemental biologics license application (sBLA) for a self-administered option of its nasal influenza vaccine FluMist Quadrivalent. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
Nuclear Regulatory Commission (NRC) has issued a Materials License for its new Indianapolis, IN headquarters. The license also expands SpectronRx’s roster of authorized nuclear pharmacists and authorized users. The license lists more than 25 different isotopes, ranging from Lutetium-177, Actinium-225, Iodine-131,and Iodine-123.
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the lifesciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Mechanisms for rapidly escalating supply must be aligned with the specific context of a rapid pandemic response and tailored to each product, with options including early voluntary licensing and appropriate approaches to peer-to-peer innovator company manufacturing agreements. . Enable affordability for lower income countries.
DOUGLAS, Isle of Man–(BUSINESS WIRE)–Juvenescence Limited (“Juvenescence”), a lifesciences company focused on modifying aging and increasing human healthspan, announced today a partnership with Evgen Pharma plc to license its sulforaphane stabilization technology for use in several non-pharmaceutical applications led … (..)
is pleased to announce that Sophia Gaulkin will be speaking on an expert panel at the 20th Advanced Summit on LifeSciences Patents , which is being held virtually and in-person in New York City on June 2-3, 2022. Hyman, Phelps & McNamara, P.C.
A field application scientist is a valuable member of any lifescience company due to their direct interaction with customers. An application scientist typically works for lifescience companies that manufacture laboratory tools or provide a service for laboratory use. Field Scientist Job Description.
Remaining compliant is imperative to the lifesciences industry, so adhering to regulatory requirements is mandatory. The provision of these records must be readily available for auditing, and failing such regulatory audits can ultimately result in a license withdrawal. As the industry increases the adoption of Pharma 4.0,
In 2018, the company also received approval for Orilissa (elagolix), which it licenses to AbbVie, for the treatment of endometriosis. Neurocrines hit drug generated $613 million in sales during the third quarter and is projected to reach $2.3 billion in revenue by 2024.
Under the deal, Merck will license its VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform. Merck and Synplogen have signed a non-binding Memorandum of Understanding (MoU) to expedite the development and manufacturing of viral vector-based gene therapy applications.
As many strive to bring about transformation in healthcare, Angelini Ventures takes a new approach to investments in digital health and lifesciences companies that drive healthcare innovation and improve patient experiences. It aims to shape companies in the digital healthcare, connected medical devices, and lifesciences spaces.
This is really what has been very challenging for upscaling viral vector production and what leads some companies that have in-licensed projects with a huge amount of viral vector to slightly panic about future production,” she says. Cytiva and the Drop logo are trademarks of LifeSciences IP Holdings Corp.
KaliVir, Astellas Pharma forms a licensing deal for VET2-L2 oncolytic virus. KaliVir Immunotherapeutics and Astellas Pharma entered into a worldwide exclusive licensing agreement for the development, research, and commercialization of VET2-L2 to widen the horizon of therapeutic approaches available in the Immuno-Oncology market.
2021 was a record year for investments in UK biotech companies, consolidating the country’s position as one of Europe’s top lifescience hubs and apparently shrugging off the effects of the pandemic and Brexit. “History has handed the UK two world-leading sectors: lifesciences and finance.
The new LifeSciences Vision details priority areas for enhancing regulation. MSD welcomed the Vision’s focus on using regulatory models to deliver fast assessments – building on the Innovative Licensing and Access Pathway (ILAP) – and ensuring accelerated approvals drive high quality real-world evidence generation.
a leading provider of integrated drug discovery services to lifescience organisations globally, is delighted that Professors Daniel Longley, Tim Harrison and colleagues at Queen’s University Belfast have entered into a collaboration and licensing agreement with Ipsen. Saffron Walden, 26th January 2022 / Domainex Ltd.,
IXCHIQ is the only licensed chikungunya vaccine in the US for adults aged 18 and older at increased risk of exposure to the virus. This includes post-marketing studies, label extensions for younger populations and a licensing agreement with the Serum Institute of India to supply the vaccine in Asia at affordable prices.
In this Pharmaceutical Commerce video interview, Joerg Tritschler, a partner in Simon-Kucher’s lifesciences division, discusses the hottest therapeutic settings for dealmaking activity at the moment—and one platform approach in particular poised to be at the center of future M&A and licensing pursuits.
Germany-based Cevec Pharmaceuticals GmbH signed a licensing agreement with Biogen for the use of its proprietary ELEVECTA Technology for the manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications. Few details of the deal were disclosed in the announcement. A second liver biopsy will be performed after 18 months.
Depending on the type of field or company, you can pursue clinical scientist jobs with a major in biology, medicine, medical technology, chemistry, immunology and other related lifescience and pre-medical degrees. In addition, some clinical scientist jobs require you to be licensed or certified.
Lead Pharma is headquartered at Pivot Park, the biopharmaceutical lifesciences campus in Oss, the Netherlands. Contact: Media Inquiries:
LifeSpring LifeSciences Communication, Amsterdam
Leon Melens
Tel.: +31 .
OSS, Netherlands , Nov. For more information visit: www.leadpharma.com.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content